Close
Nordic 9Nordic 9

Alef 6 (investor - Others)

Italy
See something wrong or missing? Let us know
Offices:Rome
Average round investment:20.37M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Italy Kither Biotech
Mostly invests in: Italy Italy (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Alef 6

Name Criteria
Italy Claris Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany 2invest
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Ace Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Panakès Partners
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy Ersel
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Roche Venture Fund
82%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Luxembourg 3B Future Health Fund
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Adjuvant Capital
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Bicycle Day Ventures
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Spain Columbus Venture Partners
80%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top